Stevens Capital Management LP Catalent, Inc. Transaction History

Stevens Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $280,403 - $370,606	-2,977 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$119.57 - $139.07 $355,959 - $414,011	2,977 New	2,977 $381,000
Q1 2021 May 11, 2021	SELL	$101.51 - $125.27 $287,577 - $354,889	-2,833 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$85.88 - $105.36 $243,298 - $298,484	2,833 New	2,833 $295,000
Q4 2017 Feb 13, 2018	SELL	$37.27 - $43.02 $2.31 Million - $2.67 Million	-61,997 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$33.75 - $41.67 $2.09 Million - $2.58 Million	61,997	61,997 $2.48 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.